Market Closed

PCSA
Processa Pharmaceuticals
$ 1.86
1.09%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Processa Pharmaceuticals News

Latest Processa Pharmaceuticals Stock News & PCSA Headlines

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
11 days ago | globenewswire.com
Processa Pharmaceuticals Announces Key Leadership Appointments
12 days ago | globenewswire.com
Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics
18 days ago | globenewswire.com
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
2 months ago | globenewswire.com
Processa Pharmaceuticals, Inc. (PCSA) M&A Call Prepared Remarks Transcript
4 months ago | seekingalpha.com
Processa buys Vidya Therapeutics, raises $200 million for drug trials
4 months ago | reuters.com
Reviewing Stevanato Group (NYSE:STVN) and Heatwurx (NASDAQ:PCSA)
7 months ago | defenseworld.net
Heatwurx (NASDAQ:PCSA) versus Aquestive Therapeutics (NASDAQ:AQST) Critical Review
7 months ago | defenseworld.net
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
10 months ago | globenewswire.com
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
10 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

PCSA
Processa Pharmaceuticals
$ 1.86
1.09%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago